Page last updated: 2024-10-22

acetohydroxamic acid and Kidney Failure, Chronic

acetohydroxamic acid has been researched along with Kidney Failure, Chronic in 2 studies

acetohydroxamic acid: urease inhibitor
oxime : Compounds of structure R2C=NOH derived from condensation of aldehydes or ketones with hydroxylamine. Oximes from aldehydes may be called aldoximes; those from ketones may be called ketoximes.
N-hydroxyacetimidic acid : A carbohydroximic acid consisting of acetimidic acid having a hydroxy group attached to the imide nitrogen.
acetohydroxamic acid : A member of the class of acetohydroxamic acids that is acetamide in which one of the amino hydrogens has been replaced by a hydroxy group.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Titan, SM1
Venturini, G1
Padilha, K1
Goulart, AC1
Lotufo, PA1
Bensenor, IJ1
Krieger, JE1
Thadhani, RI1
Rhee, EP1
Pereira, AC1
Nadler, RB1
Hoffman, TA1
McClennan, BL1
Clayman, RV1

Other Studies

2 other studies available for acetohydroxamic acid and Kidney Failure, Chronic

ArticleYear
Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort.
    PloS one, 2019, Volume: 14, Issue:3

    Topics: Aged; Biomarkers; Cohort Studies; Female; Gas Chromatography-Mass Spectrometry; Glomerular Filtratio

2019
Corynebacterium urealyticum (CDC Group D2) associated with staghorn calculus: treatment by percutaneous debulking and chemolysis.
    Journal of endourology, 1996, Volume: 10, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Follow-Up Studies; Humans

1996